Market Value1,150,089,000
Total Holdings75
File Date2015-02-17
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
WINT / Windtree Therapeutics, Inc.
ADMA / ADMA Biologics, Inc.
ANTH / Anthera Pharmaceuticals, Inc.
HRTX / Heron Therapeutics, Inc.
INFI / Infinity Pharmaceuticals Inc. Call
LJPC / La Jolla Pharmaceutical Co.
BKD / Brookdale Senior Living Inc.
885175307 / Thoratec
CORI / Corium International, Inc.
ZGNX / Zogenix Inc
PRTK / Paratek Pharmaceuticals Inc.
TENX / Tenax Therapeutics, Inc.
NVDQ / ETF Opportunities Trust - T-Rex 2X Inverse NVIDIA Daily Target ETF
SLXP / Salix Therapeuticals, Inc.
SESN / Sesen Bio Inc.
IRMD / IRADIMED CORPORATION
INFI / Infinity Pharmaceuticals Inc.
AVDL / Avadel Pharmaceuticals plc
DRRX / DURECT Corporation
HZNP / Horizon Therapeutics Plc
DVAX / Dynavax Technologies Corporation
HZNP / Horizon Therapeutics Plc Call
BDSI / Biodelivery Sciences International
FLXN / Horizon Funds - Horizon Flexible Income ETF
US2538277037 / Digirad Corp.
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
MASI / Masimo Corporation
RPTP / Raptor Pharmaceutical Corp.
MRTX / Mirati Therapeutics, Inc.
ATRC / AtriCure, Inc.
NVLN / NOVELION THERAPEUTICS INC.
UAM / Universal American Corp.
MLNT / Melinta Therapeutics, Inc.
ELOS / Syneron Medical Ltd.
REPH / Societal CDMO Inc
XNCR / Xencor, Inc.
LBMH / Liberator Medical Holdings, Inc.
CASC / Cascadian Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
TNXP / Tonix Pharmaceuticals Holding Corp.
PHIO / Phio Pharmaceuticals Corp.
ATRS / Antares Pharma Inc
CASM / CAS Medical Systems, Inc.
ALQA / Alliqua, Inc.
IDRA / Idera Pharmaceuticals, Inc.
AEGR / Aegerion Pharmaceuticals, Inc. Call
EBS / Emergent BioSolutions Inc.
451731103 / Ignyta, Inc.
US00163U1060 / AMAG Pharmaceuticals, Inc.
VXRT / Vaxart, Inc.
DXTR / Dextera Surgical Inc.
AMPH / Amphastar Pharmaceuticals, Inc.
CNMD / CONMED Corporation
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
RDHL / RedHill Biopharma Ltd. - Depositary Receipt (Common Stock)
GNMX / Aevi Genomic Medicine, Inc.
032420101 / Anacor Pharmaceuticals, Inc.
DSCI / Derma Sciences, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
PLXP / PLx Pharma Inc.
RAD / Rite Aid Corp.
PGNX / Progenics Pharmaceuticals, Inc. Call
KND / Kindred Healthcare, Inc.
HTWR / Heartware International Inc.
ANGO / AngioDynamics, Inc.
AEGR / Aegerion Pharmaceuticals, Inc.
ALBO / Albireo Pharma Inc
449575AB5 / Igi Laboratories Inc Bond
RIGL / Rigel Pharmaceuticals, Inc.
LGND / Ligand Pharmaceuticals Incorporated
PTX / Pernix Therapeutics Holdings, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
TRVN / Trevena, Inc.
AFAM / Almost Family, Inc.
PETX / Aratana Therapeutics, Inc.
ASRT / Assertio Holdings, Inc.
NTUS / Natus Medical Inc
ASPX / Auspex Pharmaceuticals, Inc.
CCXI / ChemoCentryx Inc
CLTX / Celsus Therapeutics
ARAY / Accuray Incorporated
VOLC / Volcano Corp
TVTX / Travere Therapeutics, Inc.
IPXL / Impax Laboratories, Inc.